Sponsor:
Massachusetts General Hospital
Code:
NCT06558188
Conditions
Osteoporosis, Postmenopausal
Osteoporosis
Eligibility Criteria
Sex: Female
Age: 45+
Healthy Volunteers: Accepted
Interventions
Romosozumab
Teriparatide
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-04-21. This information was provided to ClinicalTrials.gov by Massachusetts General Hospital on 2026-04-17.